Atlas Trials

Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis

Clinical trial NCT01027728 · COMPLETED

Trial details

NCT number
NCT01027728
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2009-12-01
Primary completion
2010-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.